Cargando…
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
Pharmacovigilance (PV) came suddenly into the spotlight when several new vaccines, developed as a response to the COVID-19 pandemic, received emergency authorisation and were rolled out on a large scale in late 2020. The vaccines underwent stringent clinical trials and evaluation from regulatory aut...
Autores principales: | Rudolph, Annette, Mitchell, Joseph, Barrett, Jim, Sköld, Helena, Taavola, Henric, Erlanson, Nils, Melgarejo-González, Carlos, Yue, Qun-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424876/ https://www.ncbi.nlm.nih.gov/pubmed/36052399 http://dx.doi.org/10.1177/20420986221118972 |
Ejemplares similares
-
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance
por: Calderon-Ospina, Carlos-Alberto
Publicado: (2023) -
The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
por: Quintero, Gustavo A.
Publicado: (2022) -
Self-medication and the ‘infodemic’ during mandatory preventive
isolation due to the COVID-19 pandemic
por: Gaviria-Mendoza, Andrés, et al.
Publicado: (2022) -
Drug safety of frequently used drugs and substances for self-medication in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022) -
Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy
por: Kavanagh, Oisín N.
Publicado: (2022)